Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2654929
Reference Type
Journal Article
Title
Biological monitoring and health effects of low-level exposure to N-methyl-2-pyrrolidone: A cross-sectional study
Author(s)
Haufroid, V; Jaeger, VK; Jeggli, S; Eisenegger, R; Bernard, A; Friedli, D; Lison, D; Hotz, P
Year
2014
Is Peer Reviewed?
Yes
Journal
International Archives of Occupational and Environmental Health
ISSN:
0340-0131
EISSN:
1432-1246
Volume
87
Issue
6
Page Numbers
663-674
Language
English
PMID
24078144
DOI
10.1007/s00420-013-0906-5
Web of Science Id
WOS:000339885200010
URL
http://
://WOS:000339885200010
Exit
Abstract
To examine the value of urinary 5-hydroxy-N-methyl-2-pyrrolidone (5-HNMP) and 2-hydroxy-N-methylsuccinimide (2-HMSI) in a population of workers exposed to N-methyl-2-pyrrolidone (NMP) and to look for health effects of exposure to this organic solvent.
Airborne NMP was determined according to the NIOSH method. Urinary 5-HNMP and 2-HMSI (after and before next shift) were determined by liquid chromatography with tandem mass spectrometry. Outcomes were effects on lung, kidney, skin and mucous membranes, nervous system, haematopoiesis and liver determined by clinical examination and laboratory measurements. Univariate statistical methods and multiple regressions were used to analyse results. Skin resorption, smoking and other potential confounders were taken into account.
Three hundred twenty-seven workers were eligible out of which 207 workers (63 %) participated. Ninety-one of these worked with NMP. Occupational exposure to NMP did often not occur daily and ranged from non-detectable to 25.8 mg/m(3) (median = 0.18). Urinary 2-HMSI (mg/l; before next shift) was the best biomarker of exposure to NMP, explaining about 70 % of the variance, but most likelihood ratios did not allow for ruling exposure in or out, at these low levels of exposure. Creatinine adjustment did not improve the results clearly. No clear and consistent health effects could be associated with NMP exposure. No indication for a bias due to non-participation was found.
Biological monitoring, primarily urinary 2-HMSI (mg/l; before next shift), is of value to estimate exposure to NMP even when exposure is irregular and low. Likelihood ratios of urinary 5-HMNP or 2-HMSI are, however, not quite satisfactory at these low levels. No irritant or other health effects were found.
Keywords
Biological monitoring; N-methyl-2-pyrrolidone; Skin uptake; Irritation
Tags
OPPT REs
•
OPPT_N-methylpyrrolidone (NMP)_C. Engineering
Total – title/abstract screening
On topic
Peer review
Primary source
•
OPPT_N-methylpyrrolidone (NMP)_D. Exposure
Total – title/abstract screening
Off topic
•
OPPT_N-methylpyrrolidone (NMP)_E. Fate
Total – title/abstract screening
Off topic
•
OPPT_N-methylpyrrolidone (NMP)_F. Human Health
Total – title/abstract screening
On topic
Peer review
Primary source
On topic - additional tags for titles/abstracts
Human hazard ID
•
OPPT_Perchloroethylene (Perc)_C. Engineering
Total – title/abstract screening
On topic
Peer review
Primary source
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity